BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Bioverativ Announces 2018 Annual Meeting of Stockholders

  Bioverativ announced today that its 2018 Annual Meeting of Stockholders has been scheduled for April 25, 2018.

  December 22, 2017

   · 

  1 min read
• Business

  Lattice Biologics Ltd. Announces Change in Director and Change in Status of Chief Operating Officer

  Board of Director Mario Stifano resigned his position effective December 12, 2017, due to conflicting time priorities.

  December 22, 2017

   · 

  2 min read
• 

  BioMidwest

  Zimmer Biomet Shows Off Pilot Data for nStride Knee Injection

  The pilot study enrolled 46 patients with unilateral, mild-to-moderate, symptomatic knee OA pain from the four trial sites across Europe.

  December 22, 2017

   · 

  7 min read
• 

  FDA

  Novartis’ Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data in Its Label

  Novartis announced today that the FDA approved the inclusion of Treatment-free Remission data in the Tasigna U.S. product label.

  December 22, 2017

   · 

  13 min read
• Helix BioPharma Corp. Closes Private Placement

  Helix BioPharma Corp. announced it has closed a private placement financing for gross proceeds of CAD750,600.

  December 22, 2017

   · 

  3 min read
• 

  Deals

  Roche Does Last-Minute Christmas Shopping, Drops $1.7 Billion on San Diego Biotech

  Roche got in some last-minute Christmas shopping, shelling out $1.7B for San Diego’s Ignyta.

  December 22, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Rejects Agile’s Contraceptive Patch Twirla For a Second Time

  Shares of Agile plunged more than 62 percent in early trading after the company announced this morning the FDA rejected its low-dose hormonal contraceptive patch called Twirla.

  December 22, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Arno Therapeutics Is Shuttering Its Doors

  Arno Therapeutics is calling it quits. It sold off all its assets, with the final asset being the rights to Onapristone, which it sold to Context Biopharma.

  December 22, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Biocon’s Biosimilar Arm May Raise $500M to Fund Clinical Development

  Biotechnology major BioCon is likely to take its group entity Biocon Biologics public and is expected to raise about $500M.

  December 22, 2017

   · 

  1 min read
• 

  Drug Development

  Zhejiang Medicine Terminates Phase III Oncology Trial

  Zhejiang Medicine has terminated its Phase III oncology trial for oral forms of prochloridine mesylate to treat AML due to a lack of efficacy.

  December 22, 2017

   · 

  2 min read

   · 

  Alex Keown